Thursday, 17.9.2026

0830 - 0835 Auditorium	Opening of the SGG-SASL-SVEP congress Markus Heim, Basel
0830 - 0835 Ballsaal	Opening of the SGG-SASL-SVEP congress Markus Heim, Basel
0830 - 0835 Theatersaal	Opening of the SGG-SASL-SVEP congress Markus Heim, Basel
0835 - 1000 Auditorium	Endoscopy I - Interventional EUS: meet the experts (sponsored by Olympus) simultaneous interpreting into german, French and italian Christoph Schlag, Zürich    Emanuel Burri, Liestal    Ines Friebe, Aarau
0835 - 0920 Auditorium	Endosonographic gastroenterostomy Frans Olivier The and Nursing Team from Stadtspital Zürich, Zürich
0940 - 1000 Auditorium	EUS-directed biliary drainage Reiner Wiest and Nursing Team from Inselspital Bern, Bern
0835 - 1000 Theatersaal	Inflammatory Bowel Disease Alain Schoepfer, Lausanne    Sebastian Zeissig, Bern
0835 - 0856 Theatersaal	The IBDome Sebastian Zeissig, Bern
0856 - 0917 Theatersaal	Urgency and incontinence in IBD Thomas Greuter, Lugano
0917 - 0938 Theatersaal	Management of postoperative patients with IBD Alain Schoepfer, Lausanne
0938 - 1000 Theatersaal	Legacy drugs and their place in current IBD treatment Gerhard Rogler, Zürich
0835 - 1000 Ballsaal	New Challenges in Hepatology David Semela, St. Gallen    Montserrat Fraga, Lausanne
0835 - 0856 Ballsaal	Hepatitis D: how to treat and for how long? Nasser Semmo, Bern
0856 - 0917 Ballsaal	Non-invasive testing: does etiology matter? Maja Thiele, Kopenhagen, Denmark
0917 - 0938 Ballsaal	Hepatitis E Darius Moradpour, Lausanne
0938 - 1000 Ballsaal	Evolving concepts in palliative care in advanced chronic liver disease Sumita Verma, Brighton, UK
1000 - 1030 Exhibition Area	Coffee break in the Exhibition Area
1030 - 1200 Auditorium	SGG-SASL-SVEP Joint Session - Cancer screening and surveillance - simultaneous interpreting into german, French and italian Markus Heim, Basel    Annalisa Berzigotti, Bern    Frank Bieger, Oberwil    Tobias Ehmann, Zofingen
1030 - 1052 Auditorium	Colorectal cancer screening Antoni Castells, Barcelona, Spain
1052 - 1114 Auditorium	Barretts surveillance Sachin Wani, Denver, USA
1114 - 1136 Auditorium	Personalization of HCC surveillance Pierre Nahon, Bobigny, France
1138 - 1200 Auditorium	Liquid biopsy for cancer screening Klaus Pantel, Hamburg, Germany
1200 - 1330 Exhibition Area	Lunch break in the Exhibition Area
1215 - 1245 Theatersaal	Lunch Symposium Eli Lilly
1215 - 1245 Ballsaal	Lunch Symposium Johnson&Johnson: Maintenance Matters: From Dark Matters to Deep Remission Luc Biedermann, Zürich    Pierre Michetti, Lausanne
1250 - 1320 Theatersaal	Lunch Symposium Gilead Sciences Switzerland Sàrl: Managing PBC in Clinical Practice: Guideline, Evidence, Uncertainty, and Decision-Making Andreas Kremer, Zürich    Montserrat Fraga, Lausanne
1250 - 1320 Ballsaal	Lunch Symposium Takeda Pharma AG: IBD in 2026: What’s the Verdict beyond Symptom Control? Luc Biedermann, Zürich    Pascal Juillerat, Fribourg und Bern    Sophie Restellini, Meyrin/Genève
1330 - 1500 Auditorium	The Evolving Landscape for Gastroenterologists, Hepatologists and GI Nurses - simultaneous interpreting into german, French and italian Sophie Buyse, Yverdon    Tobias Ehmann, Zofingen    Daniele Riva, Lugano
1330 - 1352 Auditorium	TARDOC und ambulante Pauschalen Ellen Utzinger, Zürich
1352 - 1414 Auditorium	Should Hepatology become an independent speciality or remain a subspeciality of Gastroenterology? David Semela, St. Gallen
1414 - 1436 Auditorium	Shortage of nursing staff in endoscopy Deepa Gandhi, Dublin, Ireland
1438 - 1500 Auditorium	Colon carcinoma screening programs in Switzerland: current status and outlook Alain Vonlaufen, Genève
1330 - 1500 Theatersaal	IBD oral presentations Gerhard Rogler, Zürich    Jan Hendrik Niess, Basel
1330 - 1355 Theatersaal	When could fecal transplantation be appropriate in IBD? Michael Scharl, Zürich
1400 - 1410 Theatersaal	The tryptophan metabolite 8-methoxykynurenate activates GPR35 to drive eosinophilic esophagitis through IL-18 and barrier dysfunction Hassan Melhem, Basel
1410 - 1420 Theatersaal	The novel anti-integrin αvβ6 autoantibodies show high diagnostic accuracy and outperform anti-neutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in distinguishing ulcerative colitis from Crohn’s disease: a prospective cross-sectional study Samuel Truniger, St. Gallen
1420 - 1430 Theatersaal	Risk of Venous Thromboembolism During Pregnancy and Postpartum in Women With Inflammatory Bowel Disease: A Swiss Population-Based Cohort and Case-Control Study Julian Heierle, Basel
1430 - 1440 Theatersaal	Dupilumab is effective and safe in refractory patients with eosinophilic esophagitis: real-world evidence from Switzerland and Austria Alain Schoepfer, Lausanne
1440 - 1450 Theatersaal	Baseline microbial ecology predicts responsiveness to D-lactate-free probiotic therapy in colitis Bahtiyar Yilmaz, Bern
1450 - 1500 Theatersaal	Upadacitinib Achieves High Rates Of Symptomatic Remission In Patients With Ulcerative Colitis After One Year Of Treatment, Regardless Of Levels Of Potential Prognostic Markers At Week 8 - Interim Data From The IBD-DACH Study EUROPE Sebastian Zeissig, Bern
1330 - 1500 Ballsaal	Hepatology oral presentations I Darius Moradpour, Lausanne    Christine Bernsmeier, Basel
1330 - 1355 Ballsaal	Clinical research in liver disease: from clinical reasoning to practice-changing evidence Annalisa Berzigotti, Bern
1400 - 1410 Ballsaal	HBsAg Cannot Reliably Report cccDNA Activity: Implications for Functional Cure Endpoints in Chronic Hepatitis B Trials Aleksei Suslov, Basel
1410 - 1420 Ballsaal	SMG6-dependent RNA decay maintains dsRNA homeostasis and restrains immunogenicity in hepatocellular carcinoma Enes S. Arpa, Lausanne
1420 - 1430 Ballsaal	Dynamic effects of microbial and host factors modulating innate immune responses in patients with acute decompensation of liver cirrhosis annalisa sanga, basel
1430 - 1440 Ballsaal	Associations between Cardiac Function and Post-Albumin Hypervolemia in Decompensated Cirrhosis Daniel Segna, Bern
1440 - 1450 Ballsaal	Direct Portal Pressure Assessment by Endoscopic Ultrasound: First Swiss Single-Centre Experience With EUS-Guided Portosystemic Pressure Gradient Measurement Using the EchoTip Insight System Rahel Häuptle, St. Gallen
1450 - 1500 Ballsaal	Living-Donor Liver Transplantation for Pembrolizumab-Induced Vanishing Bile Duct Syndrome in a Patient with Triple-Negative Breast Cancer: A Swiss Proof-of-Concept Case Hala Alrasheed, St. Gallen
1330 - 1500 Saal Brünig	SVEP-ASPE: Handson-Workshop I: ERCP (sponsored by Cook Medical, Micro-Tech, Olympus) Martin Müller, Chur
1500 - 1530 Exhibition Area	Coffee break in the Exhibition Area
1500 - 1530 Kongresssaal	Poster Walks Gastroenterology and Hepatology
1530 - 1700 Auditorium	IBD: meet the experts (sponsored by Abbvie, Johnson&Johnson, Olympus) - simultaneous interpreting into german, French and italian Stephan Brand, St. Gallen    Petr Hrùz, Basel    Dritë Rushiti, Chur
1530 - 1552 Auditorium	Innovative Therapieansätze bei IBD Jan Hendrik Niess, Basel
1552 - 1614 Auditorium	Transition in Theorie und Praxis Dimitri Rast, Basel
1614 - 1634 Auditorium	Transition: das Konzept und die Praxis: was sind die Herausforderungen? Mary-Louise Dali, Basel
1638 - 1700 Auditorium	Transition aus Sicht der Patientin / des Patienten
1530 - 1700 Theatersaal	Endoscopy oral presentations Henriette Heinrich, Basel    Patrick Aepli, Luzern
1530 - 1555 Theatersaal	EUS biliary drainage - the end of ERCP? Christoph Schlag, Zürich
1600 - 1610 Theatersaal	EDIGO: A bedside score for stratifying early adverse-event risk after initial endoscopic biliary drainage for malignant biliary obstruction Edis Gasanin, Lausanne
1610 - 1620 Theatersaal	TECHNICAL AND CLINICAL OUTCOMES OF ENDOSCOPIC GASTROENTEROSTOMY IN PATIENTS WITH BENIGN GASTRIC OUTLET OBSTRUCTION: A RETROSPECTIVE MULTICENTER STUDY IN THE DACH REGION Marie Philippart, Lausanne
1620 - 1630 Theatersaal	Endoscopic ultrasound-guided drainage of liver abscesses (EUS-LAD): Multicenter retrospective analysis of the DACH-EUS study group Ivan Yanev, Zürich
1630 - 1640 Theatersaal	Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Single-Center Experience Meddy Dalex, lausanne
1640 - 1650 Theatersaal	Endoscopic ultrasound-guided hepaticogastrostomy using temporary fully covered stents versus definitive biliary drainage with partially covered stents in the management of malignant biliary obstruction. Mustafa Iscen, Lausanne
1650 - 1700 Theatersaal	Substantial Heterogeneity in Endoscopy Training Across United European Gastroenterology Member Societies: A Cross-Sectional Analysis of National Curricula Malina Wiesand, Basel
1530 - 1700 Ballsaal	Rare Liver Diseases Session Andrea De Gottardi, Luzern    Nicolas Goossens, Genève
1530 - 1552 Ballsaal	Presentation of the Swiss Rare Liver Network Andreas Kremer, Zürich
1552 - 1614 Ballsaal	Polycystic Liver Disease Frederik Nevens, Leuven, Belgium
1616 - 1636 Ballsaal	Alagille Syndrome Björn Fischler, Stockholm, Sweden
1638 - 1700 Ballsaal	Wilsons Disease Piotr Socha, Warszawa, Poland
1530 - 1700 Saal Brünig	SVEP-ASPE: Handson-Workshop II: Polypektomie (sponsored by DesoMedical, Micro-Tech, Olympus) Gabriela Leuzinger, Winterthur
1715 - 1800 Auditorium	General Assembly SVEP-ASPE
1715 - 1800 Theatersaal	General Assembly SGGSSG
1800 - 1845 Saal Brünig	General Assembly IBDnet
1800 - 1845 Theatersaal	General Assembly SASL
1800 - 1845 Ballsaal	General Assembly MDL
1800 - 1845 Saal Harder	General Assembly Swiss NGM

Friday, 18.9.2026

0745 - 0815 Theatersaal	Early Bird Symposium MSD: Precision Begins Early – Gastroenterology at the Frontline of GI Oncology
0830 - 1000 Auditorium	Endoscopy II - POEM - Third space endoscopy: meet the experts - simultaneous interpreting into german, French and italian Reiner Wiest, Bern    Jan Borovicka, St. Gallen    Agnes Zaininger, Wien
0830 - 0915 Auditorium	POEM Henriette Heinrich, Basel
0915 - 1000 Auditorium	G-POEM Léon Finci, Genève
0830 - 1000 Theatersaal	Gastroenterology Update 2026 Andrew Macpherson, Bern    Jean-Louis Frossard, Genève
0830 - 0852 Theatersaal	Pancreatic neuroendocrine tumors: management and prognosis Sébastien Godat, Lausanne
0852 - 0914 Theatersaal	Wireless recording in funtional intestinal disease Mark Fox, Arlesheim
0914 - 0936 Theatersaal	Computational modelling in intestinal diagnosis Niko Beerenwinkel, Zürich
0938 - 1000 Theatersaal	Use of AI in gastroenterology Cesare Hassan, Milano, Italy
0830 - 1000 Ballsaal	Hepatology Hot Topics 2026 Annalisa Berzigotti, Bern    Beat Müllhaupt, Zürich
0830 - 0852 Ballsaal	MASLD: the endocrinologist point of view to a rational approach in the era of GLP1RA Cyrielle Caussy, Lyon, France
0852 - 0914 Ballsaal	Portal Hypertension in 2026: a summary of the Baveno VIII consensus conference Thomas Reiberger, Wien, Austria
0914 - 0936 Ballsaal	Endohepatology: Indications, challenges and opportunities Ilaria Tarantino, Palermo, Italy
0938 - 1000 Ballsaal	Managing Cholestatic Pruritus in 2026: Where Do IBATs Fit? Andreas Kremer, Zürich
1000 - 1030 Exhibition Area	Coffee break in the Exhibition Area
1030 - 1200 Auditorium	SGG-SASL-SVEP Joint Session - Best in Science, Practice and Care and Prize Winner Talks - simultaneous interpreting into german, French and italian Markus Heim, Basel    David Semela, St. Gallen    Alain Vonlaufen, Genève    Gabriela Leuzinger, Winterthur
1030 - 1055 Auditorium	Extracorporeal liver support using xenogeneic pig livers: Progress, Challenges, and Clinical Prospects Abraham Shaked, Pennsylvania, USA
1055 - 1105 Auditorium	Hepatology Prize 2026
1105 - 1130 Auditorium	State of the art: How to resect large polyps in the colon? Michael Bourke, Sydney, Australia
1130 - 1140 Auditorium	Gastroenterology Prize 2026
1140 - 1200 Auditorium	Nursing Roles in Caring for Patients with Crohn\'s Disease or Ulcerative Colitis Palle Bager, Aarhus, Denmark
1200 - 1330 Exhibition Area	Lunch break in the Exhibition Area
1215 - 1245 Theatersaal	Lunch Symposium AbbVie: Switch or No-Switch? Ultrasound-Guided Therapy Decisions in IBD Thomas Greuter, Lugano    Sebastian Zeissig, Bern    Sophie Restellini, Meyrin/Genève
1215 - 1245 Ballsaal	Lunch Symposium Schwabe Pharma: “Functional Dyspepsia and IBS in Practice: A Gut–Brain Update with New Phase IV Evidence Jeanine Wakim El-Khoury, Lausanne    Ioannis Linas, Bern
1250 - 1320 Ballsaal	Lunch Symposium Ipsen Pharma Schweiz GmbH: Seeing the Unseen: Uncovering Genetic Cholestatic Diseases in Everyday Hepatology Practice Andreas Kremer, Zürich    Valérie McLin, Genève
1250 - 1320 Theatersaal	Lunch Symposium Sanofi-Aventis (Schweiz) AG
1330 - 1500 Auditorium	Functional Gastroenterology - simultaneous interpreting into german, French and italian Daniel Pohl, Zürich    Lukas Degen, Basel
1330 - 1352 Auditorium	Global prevalence, characterization and impact of Functional Bowel Disorders Tom Van Gils, Göteborg, Sweden
1352 - 1414 Auditorium	Pathophysiological Mechanisms of Functional Gastrointestinal Disorders Vassilis Pachnis, London, UK
1414 - 1436 Auditorium	Personalized Management Strategies in Functional Gastrointestinal Disorders Giovanni Barbara, Bologna, Italy
1438 - 1500 Auditorium	The role of manometry, impedance and FLIP in diagnosis and classification of functional GI disorders Sabine Roman, Lyon, France
1330 - 1500 Theatersaal	Gastroenterology oral presentations Sebastian Zeissig, Bern    Kaspar Truninger, Zürich
1330 - 1355 Theatersaal	Management of pancreatic cysts Reiner Wiest, Bern
1400 - 1410 Theatersaal	Reactivation of a mid-embryonic program drives progenitor identity in colorectal cancer Hassan Fazilaty, Zurich
1410 - 1420 Theatersaal	Microbial and immunologic characteristics of the recipient are associated with beneficial responses to fecal microbiota transfer in patients with cancer immunotherapy-refractory solid tumors Luca Truscello, Zürich
1420 - 1430 Theatersaal	Early recovery of driving-related cognitive performance following propofol-only sedation for outpatient endoscopy. Sahar Mack, Geneva
1430 - 1440 Theatersaal	Intestinal barrier (IB) dysfunction assessed by confocal laser endomicroscopy (CLE) correlates with cirrhosis severity and clinical outcome Reiner Wiest, Bern
1440 - 1450 Theatersaal	Functional Lumen Imaging Probe (FLIP) Esophageal Motility Patterns Outperform Distensibility Metrics in Differentiating Functional Heartburn From Reflux Disease Franziska Jung, Sankt Gallen
1450 - 1500 Theatersaal	Microbiome Modulation as a Strategy to Enhance Immunotherapy in Metastatic CRC Maria Walker, Zürich
1330 - 1500 Ballsaal	Hepatology oral presentations II Andreas Kremer, Zürich    Magdalena Filipowicz Sinnreich, Liestal
1330 - 1355 Ballsaal	Machine perfusion Philipp Dutkowski, Basel
1400 - 1410 Ballsaal	Discovery of Novel MRGPRX4 Agonists and Antagonists with Implications for Hepatobiliary Pruritus Silvia Pickering, Zurich
1410 - 1420 Ballsaal	Pharmacological effects of edoxaban and apixaban in patients with liver cirrhosis montserrat fraga, Lausanne
1420 - 1430 Ballsaal	Atezolizumab/Bevacizumab for Recurrent Hepatocellular Carcinoma After Liver Transplantation: First Swiss Experience Hala Alrasheed, St. Gallen
1430 - 1440 Ballsaal	Selective Targeting Of The Blood-Biliary Barrier Ameliorates Fibrotic and Cholestatic Liver Damage by Enhancing Bicarbonate Secretion and Bile Dynamics. Felix Baier, Bern
1440 - 1450 Ballsaal	Early disease activity assessment in patients with alveolar echinococcosis: a Swiss single-centre retrospective study. Jakob Heinkele, Zürich
1450 - 1500 Ballsaal	Predictive Factors For Explantation Or Mortality After Tunneled Peritoneal Catheters In Patients With Cirrhosis And Refractory Ascites : A Swiss Multicentre Retrospective Study Jérémy Hassoun*, Geneve
1500 - 1530 Exhibition Area	Coffee break in the Exhibition Area
1530 - 1700 Auditorium	Tour de Suisse 2026 - Tips and tricks for daily clinical practice - simultaneous interpreting into german, French and italian Peter Bauerfeind, Luzern    Beat Müllhaupt, Zürich    Jean-Louis Frossard, Genève
1530 - 1540 Auditorium	How do I do hepaticgastrostomy Sébastien Godat, Lausanne
1540 - 1550 Auditorium	How do I start and maintain immunosuppression in autoimmune hepatitis  Benedetta Terziroli Beretta-Piccoli, Bellinzona
1550 - 1600 Auditorium	How do I diagnose and treat functional dyspepsia? Daniel Pohl, Zürich
1600 - 1610 Auditorium	How do I do a colo-enterostomy Christoph Schlag, Zürich
1610 - 1620 Auditorium	Therapy of Wilsons disease: How do I choose and dose the drug, and how do I monitor and adjust the therapy? Montserrat Fraga, Lausanne
1630 - 1640 Auditorium	How to prepare a patient psychologically for liver transplantation
1640 - 1650 Auditorium	How do I dilate esophageal stenosis in EOE? Alain Schoepfer, Lausanne
1650 - 1700 Auditorium	MASLD: What are the most efficient lifestyle advices?  David Semela, St. Gallen
1530 - 1700 Theatersaal	Young Gastroenterologists Henriette Heinrich, Basel    Robert Brenig, Basel
1530 - 1552 Theatersaal	How to slay the exam Jasmina El Hadad, Zürich
1552 - 1614 Theatersaal	Disorders of Gut-Brain Interaction for the exam Valeria Schindler, Zürich
1614 - 1636 Theatersaal	Gi Bleeding – Universal truths for the exam Ron Fried, Zürich
1636 - 1700 Theatersaal	Liver diseases: key points for exam preparation Robert Brenig, Basel
1530 - 1700 Ballsaal	Abdominal Sonography Course (SGUM accreditated, separate inscription: office@sggssg.ch) Irina Bergamin, St. Gallen    Pamela Meyer-Herbon, St. Gallen    Livia Kammerlander, Winterthur

---

Posters

Gastroenterology

Gastroenterology 1	Peripheral Blood–Associated Microbial Signatures as Predictors of Therapy Response in Inflammatory Bowel Disease Vanessa Dobernig, Celine Mamie, Yasser Morsy, Michael Scharl Department of Gastroenterology and Hepatology; University Hospital Zürich; Zürich; Switzerland
Gastroenterology 2	Update 2026 on the Swiss Eosinophilic Esophagitis Cohort Catherine Saner1, Ekaterina Safroneeva2, Jean-Benoit Rossel2, Emanuel Burri3, Patrick Aepli4, Annett Franke5, Luc Biedermann6, Thomas Greuter1,7, Peter Netzer8, Alex Straumann6, SEECS group, Alain Schoepfer1 1CHUV, Lausanne, 2ISPM Bern, 3US Baselland, 4LUKS, 5KS St. Gallen, 6US Zuerich, 7EOC Lugano, 8GastroZentrum Bern
Gastroenterology 3	Eosinophilic Cholangitis mimicking Cholangiocarcinoma Sebastian Rupp, Simon Bütikofer Department of Gastroenterology and Hepatology; Luzerner Kantonsspital; Luzern
Gastroenterology 4	Helicobacter pylori Antibiotic Resistance Patterns in Zürich Johannes Hegner, Frank Imkamp, Fritz Murray, Christoph Gubler, Bernhard Morell Dept. of Gastroenterology and Hepatology, Stadtspital Zürich Institute of Medical Microbiology, University of Zurich
Gastroenterology 5	Single-Session EUS-Guided Gastroenterostomy (EUS-GE) and Hepaticogastrostomy (EUS-HGS) for Malignant Double Obstruction Riad Sarraj¹, Jens Fechner¹, Bliona Muji¹, Reiner Wiest¹ Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital Bern
Gastroenterology 6	Case Report: When Breast Cancer Reaches the Gut Thomas Hofer, Tassili A.F. Weehuizen , Sandra Hürlimann Luzerner Kantonsspital, Lucerne
Gastroenterology 7	Massive gastrointestinal bleeding caused by Meckel’s divertic-ulum in a young adult: a diagnostic challenge Tassili A.F. Weehuizen1, Thomas F. Hofer1 Departement of Gastroenterology & Hepatology, Luzerner Kan-tonsspital, Lucerne.
Gastroenterology 8	Sustained Improvement In Patient-Reported Outcomes With Long-Term Risankizumab Treatment In Patients With Moderately To Severely Active Ulcerative Colitis: Interim 2-Year Results From The Phase 3 COMMAND Open-Label Extension Study L. Biedermann1, J. Panés2, S. Danese3, S. Tanida4, P.S. Dulai5, N. Shukla6, J. Kalabic7, P. Morisset6, C. Holweg6, D. Sharma6, J. Torres8 1USZ Zürich, Gastroenterology & Hepatology, Zürich, Switzerland, 2Hospital Clínic Barcelona, Dept. of Gastroenterology, Barcelona, Spain, 3Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Gastrointestinal immunopathology, Milan, Italy, 4Gamagori City Hospital, Division of Gastroenterology, Gamagori, Japan, 5Northwestern University, Division of Gastroenterology and Hepatology, Chicago, United States of America, 6AbbVie, North Chicago, United States of America, 7AbbVie Deutschland GmbH Co. KG, Ludwigshafen am Rhein, Germany, 8Hospital Beatriz Ângelo & Hospital da Luz, Gastroenterology, Lisbon, Portugal USZ
Gastroenterology 9	Looking Back to Move Forward: Preliminary Real-World Guselkumab Outcomes in Pre-Approval-Treated IBD Patients with Psoriatic Comorbidity (SPHERE-IBD) L. Biedermann1, E. Burri2, T. Greuter3, Christiane Sokollik4, Pascal Juillerat5, G. Rogler¹, Pierre Michetti6 on behalf of the SPHERE-IBD Study Group and the Swiss IBD Registry 1Dept. of Gastroenterology and Hepatology, University Hospital Zurich; 2Dept. of Gastroenterology and Hepatology, Kantonsspital Liestal, University of Basel;3Division of Gastroenterology and Hepatology, EOC Lugano, Università della Svizzera italiana, Lugano; 4Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital, Inselspital, University of Bern;5Crohn and Colitis Centre, Gastroenterology Intesto, Bern and Fribourg, Switzerland 6Crohn and Colitis Center, Gastroentérologie Beaulieu SA, Lausanne, Switzerland USZ
Gastroenterology 10	Patient-Reported Adherence To ECCO Guidelines Across The DACH Region Christa L. Bodmer1, Claire M. Nötel1, Luc Biedermann1, Alain Schöpfer2, Thomas Greuter3, Stephan Vavricka4, Gerhard Rogler1 1 Department of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland 2 Department of Gastroenterology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland 3 Ospedale Regionale di Lugano, Civico 4 Zentrum für Gastroenterologie und Hepatologie Zürich
Gastroenterology 11	Long-term outcome after endoscopic ultrasound-guided pancreatic duct drainage Anouk Voutaz, Elodie Romailler, Mariola Marx, Meddy Dalex, Marie Philippart, Domenico Galasso, Sébastien Godat eHnv, Yverdon-les-Bains, Switzerland; CHUV, Lausanne, Switzerland
Gastroenterology 12	SpyGlass-assisted pancreatoscopic lithotripsy for main pancreatic duct stones in chronic calcific pancreatitis: a single-center retrospective cohort study Anton Gambardella, MSc, Tommy Rizkala, MD, Meddy Dalex, MD, Marie Philippart, MD, François Kungu, MD, Basile Keshavjee, MD, Domenico Galasso, MD, Sébastien Godat, MD Department of Gastroenterology and Hepatology, CHUV, Lausanne, Switzerland
Gastroenterology 13	FLIP Measurements Predict Short-Term Outcomes After Singular EsoFLIP Dilation in Patients with Achalasia Johann Stuby, Valeria Schindler, Joel Schnellmann, Jessica Martinez, Daniel Pohl Department of Gastroenterology and Hepatology, Zürich University Hospital
Gastroenterology 14	Guideline Adherence In Coeliac Disease Care Across The DACH Region: A Patient-Reported Study Claire M. Nötel, Christa L. Bodmer, Michael Scharl, Jonas Zeitz, Diana Studerus, Luc Biedermann, Stephan Vavricka, Gerhard Rogler 1) University Hospital Zurich, Switzerland 2) GastroZentrum, Klinik Hirslanden, Zurich, Switzerland 3) Zentrum für Gastroenterologie & Hepatologie, Zurich, Switzerland
Gastroenterology 15	Applicability of the Lyon ESD Score in a Swiss University Hospital : A Retrospective Analysis of colorectal ESD Finci Léon, Lepilliez Vincent, Bichard Philippe, Frossard Jean-Louis 1Service of Gastroenterology and Hepatology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1211 Genève 2 Hépato-Gastro-Entérologie, Hôpital Privé Jean Mermoz, Lyon, France
Gastroenterology 16	VACstent XL ® as part of the endoscopic tools for complex esophageal dehiscence : a tertiary single-center swiss experience François Kungu, Mariola Marx, Meddy Dalex, Marie Philippart, Domenico Galasso, Tommy Rizkala, Sébastien Godat. Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Gastroenterology 17	Mass-forming Fibromatosis-like Gallbladder Disease Mimicking Malignancy of the Bile Duct Jasmina El Hadad Christoph Gubler Gastroenterology and Hepatology Unit, Stadtspital Zurich, Zurich, Switzerland
Gastroenterology 18	A haircut before surgery: Endoscopic scissor-assisted fragmentation of a trichobezoar with Rapunzel syndrome Stephan Baumeler, Miriam Luxenhofer, Philipp Szavay, Ilaria Luperi, Franziska Righini-Grunder Division of Gastroenterology and Hepatology, Luzerner Kantonsspital, Lucerne, Switzerland Division of Pediatric surgery and Division of Pediatric Gastroenterology, Hepatology and Nutrition, Kinderspital Zentralschweiz, Luzerner Kantonsspital, Lucerne, Switzerland
Gastroenterology 19	Patients prefer oral, Healthcare Professionals prefer subcutaneous: mode-of-delivery preferences in IBD differ by prior advanced-therapy exposure — the CHOOSE study Anouk Lehmann1, Bruno Giardina2, Elina Wüthrich1, Stephan R Vavricka3, Luc Biedermann3, Alain M Schoepfer4, Thomas Greuter5, Emanuel Burri1 Gastroenterologie und Hepatologie, Universitäres Zentrum für Innere Medizin, Kantonsspital Baselland, Liestal
Gastroenterology 20	High Shared Decision-Making Scores Mask Preference Gaps Between IBD Patients and Healthcare Professionals: The CHOOSE Study Anouk Lehmann1, Bruno Giardina2, Elina Wüthrich1, Stephan R Vavricka3, Luc Biedermann3, Alain M Schoepfer4, Thomas Greu- ter5, Emanuel Burri1 Gastroenterologie und Hepatologie, Universitäres Zentrum für Innere Medizin, Kantonsspital Baselland, Liestal
Gastroenterology 21	Major Adverse Cardiovascular Events During Pregnancy and Postpartum in Women With Inflammatory Bowel Disease: A Swiss Population-Based Cohort and Case-Control Study Julian E. Heierle¹, Christian Eichhorn¹, Carole A. Marxer², Alexander Kutz³ ⁴, Flurina Gass¹, Jan Hendrik Niess¹ ⁵, Petr Hruz¹, Anders Forss² ⁶, Fahim Ebrahimi¹ ² ¹University Hospital Basel, Department of Gastroenterology and Hepatology, ²Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden, ³Kantonsspital Aarau, Medical University Department, ⁴University of Basel, Medical Faculty, ⁵University of Basel, Department of Biomedicine, ⁶Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden
Gastroenterology 22	Disease burden measured by the IBD-Disk shows sex-specific differences in Ulcerative Colitis and is reduced by upadacitinib – Interim results from the IBD-DACH Study EUROPE M. Wiestler (1), R. Schmelz (2), U. Helwig (3,4), A.R. Moschen (5), T. Greuter (6), I. Fischer (7), J. Martin (8), S. Rath (8), T. Kucharzik (9), C. Maaser (10), S. Zeissig (11) 1Hannover Medical School MHH, Gastroenterology- Hepatology- Infectious Diseases and Endocrinology OE 6810, Hannover, Germany, 2University Hospital Dresden, Department of Gastroenterology, Dresden, Germany, 3Medical Practice for Internal Medicine, Gastroenterology practice, Oldenburg, Germany, 4University of Kiel, Department of Internal Medicine, Kiel, Germany, 5Johannes Kepler University Linz, University Clinic for Internal Medicine 2, Linz, Austria, 6Department of Gastroenterology, EOC Lugano, Switzerland, 7Biostatistik Tübingen, Biostatistik Tuebingen, Tübingen, Germany, 8AbbVie Deutschland GmbH & Co. KG, Medical Department, Wiesbaden, Germany, 9Hospital Lüneburg, Department of Internal Medicine and Gastroenterology, Lüneburg, Germany, 10Hospital Lüneburg, Outpatients Department of Gastroenterology, Lüneburg, Germany, 11Bern University Hospital, Univerity Clinic for Visceral Surgery and Medicine, Bern, Switzerland
Gastroenterology 23	Long-term monitoring of colonic function in-vivo: from preclinical application to clinical translation Arielle Planchette, Karissa Humailo, Yoseline Cabara, Karol Wojcicki, Etienne de Montalivet, Aleksander Sobolewski, Michel Neunlist, Michalina Gora-Gioux Wyss Center for Bio and Neuroengineering, TENS Unit INSERM Nantes France
Gastroenterology 24	Peroral Endoscopic Myotomy after surgical fundoplication: A single-center retrospective experience Mael Vicario, Mariola Marx, Meddy Dalex, Marie Philippart, Francois Kungu, Domenico Galasso, Tommy Rizkala, Sébastien Godat Service de gastro-entérologie et d’hépatologie, CHUV, Lausanne
Gastroenterology 25	Guselkumab Real-World Experience in Switzerland: Which Dose, Which Formulation, and For Whom? A Swiss Multicenter Report of 72 IBD Patients. Pascal Juillerat* (1,2,3), Roseline Ruetsch, (2), Vasili Oikonomou (2,3), Rosalie Compton (1), Dominique Staudenmann (1), Cyrille Frei (1), Christophe Matter (1) and Frank Seibold (1). (1) Gastroenterology, Intesto KLG, Bern and Fribourg. (2) Gastroenterology center, Bulle. (3) Gastroenterology, Clinic for Visceral Surgery and Medicine, Bern University Hospital, Inselspital.
Gastroenterology 26	A Postmarketing, Prospective, Noninterventional Study Evaluating the Real-World Clinical Effectiveness and Safety of Risankizumab in Patients with Crohn’s Disease: Interim Results from the APPRISE Study P. Bossuyt1, T. Hisamatsu2, R. Atreya3, J. Tinoco da Silva Torres4, F. Aponte5, M. Mallick6, S.H. Chen7, K. Kligys8, P. Juillerat9 (1) Imelda General Hospital Bonheiden, Department of Gastroenterology, Bonheiden, Belgium, (2) Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Tokyo, Japan, (3) University Hospital Erlangen- Friedrich-Alexander University Erlangen-Nürnberg, Department of Medicine I, Erlangen, Germany, (4) Surgical Department- Gastroenterology Division, Hospital da Luz & Hospital Beatriz ÂngeloLoures, and Faculdade de Medicina- Universidade de Lisboa- Lisbon, Portugal, (5) AbbVie Inc., International Medical Affairs - Gastroenterology, North Chicago, United States, (6) AbbVie Inc., Statistics - Global Medical Affairs & Health Technology Assessment, North Chicago, United States, (7) AbbVie Inc., Statistics, North Chicago, United States, (8) AbbVie Inc., Medical Affairs - International Gastroenterology, North Chicago, United States, 9Crohn and Colitis center- Intesto Bern & Fribourg, Gastroenterology, Bern, Switzerland
Gastroenterology 27	Gastritis Cystica Profunda: Diagnostic Challenges and Management Algorithm– A Systematic Review Nathalie Huber, Peter Bauerfeind, Christine N. Manser Department of Gastroenterology and Hepatology, Cantonal Hospital Frauenfeld, Frauenfeld, Switzerland Department of Gastroenterology and Hepatology, Hirslanden Clinics, Zurich and Lucerne, Switzerland
Gastroenterology 28	Endoscopic ultrasound-guided gastroenterostomy for the treatment of benign upper gastrointestinal obstructions: long-term efficacy and safety M. Philippart (1), M. Dalex (1), B. Keshavjee (1), E. Romailler (1), M. Marx (1), S. Godat (1) (1) Gastroenterology Department, Centre hospitalier universitaire vaudois, Lausanne, Suisse Gastroenterology Department, Centre hospitalier universitaire vaudois, Lausanne, Suisse
Gastroenterology 29	Diagnosis of colorectal cancer in pregnancy – A case series Tabea Pfister1 Riad Sarraj 1 Martin Berger 2 Anda P Radan 3 Lukas Brügger 1 Reiner Wiest1 1 Department of Visceral Medicine and Surgery, University Hospital Bern 2 Department of Medical Oncology, University Hospital Bern 3 Department of Obstetrics and Gynecology, University Hospital Bern

Hepatology

Hepatology 1	Body Mapping Reveals Distinct Topographical Patterns of Hepatobiliary Pruritus Miriam M. Düll, Vanessa Karlen, Jonas Schmid, Peter Dietrich, Markus F. Neurath, Sonja Ständer, Martin Schmelz, Martin Metz, Tomasz Hawro, Andreas E. Kremer 1 Department of Medicine 1, University Hospital and Friedrich-Alexander-University Erlangen-Nürnberg, Germany 2 Deutsches Zentrum Immuntherapie DZI, Erlangen, Germany 3 Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, Germany 4 Department of Dermatology and Center for Chronic Pruritus, University Hospital Münster, Germany 5 Department of Experimental Pain Research Mannheim, University of Heidelberg, Germany 6 Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Germany 7 Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany 8 Department of Dermatology, Allergology and Venereology, University Hospital Schleswig-Holstein, Lübeck, Germany 9Institute for Inflammation Medicine, University of Lübeck, Lübeck, Germany 10Department of Gastroenterology and Hepatology, University Hospital Zürich, University of Zürich, Switzerland
Hepatology 2	Regional Heterogeneity in Primary Biliary Cholangitis: GLOBE and UK-PBC Score Performance in German- Versus Italian-Speaking Swiss Patients Beatrice Barda1,2, Claudia Di Bartolomeo1, Rossella Forlenza1, Andreas Cerny1,2, Giulia Magini3, Guido Stirnimann4, David Semela5, Christine Bernsmeier6, Andreas E. Kremer7, Björn Becker8, Simon Brunner9, Christinet Montserrat Fraga10, Andrea De Gottardi11, Magdalena Filipowicz12, Stephan Böhm13, Benedetta Terziroli-Piccoli14, Maurizia Bissig1, Antonio Galante2. 1Fondazione Epatocentro Ticino, Lugano 2Epatocentro Ticino, Lugano 3HUG - Hôpitaux universitaires de Genève 4Inselsspital, Bern 5HOCH Health Ostschweiz, St Gallen 6Clarunis Universitäres Bauchzentrum Basel 7Universitätsspital Zürich - USZ 8KSW Kantonsspital Winterthur 9Kantonsspital Graubünden, Chur 10Centre hospitalier universitaire vaudois -CHUV, Lausanne 11Luzerner Kantonsspital 12University of Basel -Unibas 13Spital Bülach 14Ente Ospedaliero Cantonale -EOC, Lugano
Hepatology 3	Bioequivalence of Trientine Dihydrochloride Capsules Guido Stirnimann, Steffen Wahler, Karl Heinz Weiss Universitätsklinik für Viszerale Chirurgie und Medizin, University Hospital Inselspital and University of Bern, Bern, Switzerland St. Bernward GmbH, Germany Heidelberg University, Germany
Hepatology 4	Borrelia afzelii Hepatitis: a rare manifestation of Lyme borreliosis in two immunocompromised patients Angela Renggli, Silke Klapdor, Andrea De Gottardi Luzerner Kantonsspital
Hepatology 5	Breaking the Itch: IBAT Inhibitors in Adults with Refractory Cholestatic Pruritus Loreta Kavaliukaite, Ansgar Deibel, Robert Brenig, Christine Bernsmeier, Andreas E. Kremer Department of Gastroenterology and Hepatology, University Hospital Zürich; University of Zürich; Gastroenterology and Hepatology, University Centre for Gastrointestinal and Liver Diseases, University Hospital Basel
Hepatology 6	Real-world use and metabolic trajectories of liver transplant recipients treated with GLP-1 receptor agonists: A single-centre retrospective cohort study Marine Jacquinod, Natasha Ollier, Lucie Favre, Joana Vieira Barbosa, Montserrat Fraga, Darius Moradpour, Julien Sauser, Philippe Compagnon, Giulia Magini, Nicolas Goossens, Manuel Pascual, Dela Golshayan and Julien Vionnet Lausanne University Hospital and University of Lausanne Geneva University Hospitals and University of Geneva
Hepatology 7	Chronic viral hepatitis and pregnancy outcomes: a retrospective study Celine Daelemans, Vanessa Weber, Hélène Legardeur, Montserrat Fraga, Joana Vieira Barbosa Lausanne University Hospital (CHUV), Switzerland
Hepatology 8	Effect of ANIT-induced cholestasis on liver inflammation and fibrosis Teresa De Enrique1,2, Felix Baier1, Adrian Keogh1, Corina Krummenacher1, Daniel Sanchez-Taltavull1, Tural Yarahmadov1, Daniel Candinas1, Deborah Stroka1 1Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern 2Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern
Hepatology 9	Lymphocyte Transformation Testing as an Adjunctive Tool for Causality Assessment in Drug-Induced Liver Injury: The Largest Histologically Characterized Cohort to Date Christina Lins (1), Roman Stillhard (1), Sebastian Tschernitz (2), Barbara Ballmer-Weber (2), Werner Pichler (3), Pamela Meyer-Herbon (1), Irina Bergamin (1), David Semela (1) 1) Department of Gastroenterology and Hepatology, HOCH Health Ostschweiz, St. Gallen 2) Department of Dermatology and Allergology, HOCH Health Ostschweiz, St. Gallen 3) Adverse Drug Reactions Analysis & Consulting ADR AC, Bern.
Hepatology 10	Biochemical–Structural Discordance in Hepatic Sarcoidosis: A Single-Center Cohort Study Mirjam Kolev 1*, Martin Wartenberg 2*, Clara Dratva 1, Nasser Semmo 1 *shared first authorship 1 Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland 2 Institute of Tissue Medicine and Pathology, University of Bern, Switzerland
Hepatology 11	B-Cell Activation Signatures Are Independently Associated With Adverse Clinical Outcomes in Primary Biliary Cholangitis Mirjam Kolev1, Stefanie Schönenberger1, Daniel Guggisberg2, Nasser Semmo*1, Kerstin Klein*2 *Shared last authors 1 Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland 2 Department for BioMedical Research, Lung Precision Medicine, University of Bern, Switzerland